Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway

Ri Youn Kim; Hoon Joo Yang; Yun Mi Song; Il Young Kim; Soon Jung Hwang

doi:10.1089/ten.tea.2014.0585

journal article Jul 01, 2015

Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway

Ri Youn Kim Hoon Joo Yang Yun Mi Song Il Young Kim Soon Jung Hwang

Tissue Engineering Part A Vol. 21 No. 13-14 pp. 2076-2088 · SAGE Publications

View at Publisher Save 10.1089/ten.tea.2014.0585

Topics

No keywords indexed for this article. Browse by subject →

References

43

[1]

10.7326/0003-4819-117-1-1

[2]

Dupont S. Development (2000) 10.1242/dev.127.19.4277

[3]

10.1016/j.cell.2007.07.025

[4]

10.1002/jbmr.128

[5]

10.1016/j.bone.2011.04.015

[6]

10.1210/jc.2009-2283

[7]

10.1359/jbmr.1998.13.7.1124

[8]

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

Rutger L. van Bezooijen, Peter ten Dijke, Socrates E. Papapoulos et al.

Cytokine & Growth Factor Reviews 10.1016/j.cytogfr.2005.02.005

[9]

Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts

Nobuhiro Kamiya, Tatsuya Kobayashi, Yoshiyuki Mochida et al.

Journal of Bone and Mineral Research 10.1359/jbmr.090806

[10]

10.1242/dev.025825

[11]

10.1074/jbc.m413274200

[12]

10.1016/j.bone.2007.12.224

[13]

10.1074/jbc.m705092200

[14]

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Xiaodong Li, Michael S Ominsky, Qing-Tian Niu et al.

Journal of Bone and Mineral Research 10.1359/jbmr.080216

[15]

10.1359/jbmr.090411

[16]

10.1016/j.bone.2004.04.019

[17]

BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing

Kunikazu Tsuji, Amitabha Bandyopadhyay, Brian D Harfe et al.

Nature Genetics 10.1038/ng1916

[18]

10.1126/science.150.3698.893

[19]

10.1359/jbmr.080809

[20]

10.1016/j.devcel.2005.02.017

[21]

10.1359/jbmr.081206

[22]

10.1002/jbmr.14

[23]

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al.

New England Journal of Medicine 10.1056/nejmoa1305224

[24]

10.1056/nejme1315500

[25]

10.1016/j.gene.2011.02.002

[26]

10.1074/jbc.m504612200

[27]

10.1089/ten.tea.2010.0408

[28]

10.1385/mb:20:3:245

[29]

Kim I.S. Dev Growth Differ (2008) 10.1111/j.1440-169x.2008.01052.x

[30]

10.1097/maj.0b013e31820865d5

[31]

10.1128/mcb.01550-06

[32]

10.1677/erc.0.0070017

[33]

10.1038/nchembio.2007.54

[34]

10.1016/s0092-8674(00)80133-6

[35]

10.1359/jbmr.061002

[36]

10.1093/hmg/10.5.537

[37]

10.1136/jmg.39.2.91

[38]

10.1074/jbc.274.19.12971

[39]

Almeida M. J Bone Miner Res (2010) 10.1359/jbmr.091017

[40]

10.1074/jbc.m112.344747

[41]

10.1074/jbc.c400331200

[42]

10.1002/jcb.20253

[43]

10.1016/j.biomaterials.2013.11.029

Metrics

55

Citations

43

References

Details

Published: Jul 01, 2015
Vol/Issue: 21(13-14)
Pages: 2076-2088
License: View

Authors

R

Ri Youn Kim

Department of Maxillofacial Cell and Developmental Biology, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

H

Hoon Joo Yang

Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

Y

Yun Mi Song

Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

I

Il Young Kim

Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

S

Soon Jung Hwang

Department of Maxillofacial Cell and Developmental Biology, School of Dentistry, Seoul National University, Seoul, Republic of Korea.; Department of Oral and Maxillofacial Surgery, School of Dentistry, Seoul National University, Seoul, Republic of Korea.; Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

Cite This Article

Ri Youn Kim, Hoon Joo Yang, Yun Mi Song, et al. (2015). Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway. Tissue Engineering Part A, 21(13-14), 2076-2088. https://doi.org/10.1089/ten.tea.2014.0585

Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway

You May Also Like